These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2146038

  • 41. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER.
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [Abstract] [Full Text] [Related]

  • 42. What you should know about thrombolytic therapy for acute MI.
    Aragon D, Martin M.
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract] [Full Text] [Related]

  • 43. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP, Hanssen M.
    Drugs; 1987 Sep; 33 Suppl 3():247-52. PubMed ID: 2445540
    [Abstract] [Full Text] [Related]

  • 44. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators.
    O'Connor CM, Meese RB, McNulty S, Lucas KD, Carney RJ, LeBoeuf RM, Maddox W, Bethea CF, Shadoff N, Trahey TF, Heinsimer JA, Burks JM, O'Donnell G, Krucoff MW, Califf RM.
    Am J Cardiol; 1996 Apr 15; 77(10):791-7. PubMed ID: 8623729
    [Abstract] [Full Text] [Related]

  • 45. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G, Charbonnier B.
    Arch Mal Coeur Vaiss; 1990 Feb 15; 83 Spec No 1():25-9. PubMed ID: 2108643
    [Abstract] [Full Text] [Related]

  • 46. Current status of thrombolysis in acute myocardial infarction. I. Optimal selection and delivery of a thrombolytic drug.
    Habib GB.
    Chest; 1995 Jan 15; 107(1):225-32. PubMed ID: 7813283
    [No Abstract] [Full Text] [Related]

  • 47. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.
    JAMA; 1996 Mar 13; 275(10):777-82. PubMed ID: 8598594
    [Abstract] [Full Text] [Related]

  • 48. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.
    Woo KS, White HD.
    Pharmacoeconomics; 1993 Mar 13; 3(3):192-204. PubMed ID: 10172049
    [Abstract] [Full Text] [Related]

  • 49. Thrombolytic therapy: then and now.
    Cole PL.
    Heart Lung; 1991 Sep 13; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [Abstract] [Full Text] [Related]

  • 50. [Thrombolytic therapy].
    de Gaetano G, Donati MB, Gensini GF, Restagno C.
    Recenti Prog Med; 1993 Sep 13; 84(9):581-5. PubMed ID: 8210621
    [No Abstract] [Full Text] [Related]

  • 51. [Which thrombolytic agents as therapy in acute myocardial infarct?].
    Strauer BE.
    Med Klin (Munich); 1992 Feb 15; 87(2):81-2. PubMed ID: 1542287
    [No Abstract] [Full Text] [Related]

  • 52. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Rothbard RL.
    Drugs; 1987 Feb 15; 33 Suppl 3():276-8. PubMed ID: 3315606
    [Abstract] [Full Text] [Related]

  • 53. A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction.
    de Bono DP.
    Drugs; 1987 Feb 15; 33 Suppl 3():138-9. PubMed ID: 3315580
    [No Abstract] [Full Text] [Related]

  • 54. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Bucknall C, Darley C, Flax J, Vincent R, Chamberlain D.
    Br Heart J; 1988 Jan 15; 59(1):9-11. PubMed ID: 2963655
    [Abstract] [Full Text] [Related]

  • 55. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.
    Julian DG, Borthwick LS, Reid D, Jennings KP, Wainwright RJ, Rodger JC, Wood D, Phillips WS.
    Drugs; 1987 Jan 15; 33 Suppl 3():261-7. PubMed ID: 3315604
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.